1. Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over time. (June 2021) Authors: Thomson, Sasha; Witzke, Noah; Gyawali, Bishal; Delos Santos, Seanthel; Udayakumar, Suji; Cardone, Claudia; Cheung, Matthew C.; Chan, Kelvin K.W. Journal: European journal of cancer Issue: Volume 150(2021) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer. (October 2020) Authors: Cardone, Claudia; Blauensteiner, Bernadette; Moreno-Viedma, Veronica; Martini, Giulia; Simeon, Vittorio; Vitiello, Pietro P.; Ciardiello, Davide; Belli, Valentina; Matrone, Nunzia; Troiani, Teresa; Morgillo, Floriana; Zito Marino, Federica; Dentice, Monica; Nappi, Annarita; Boccaccino, Alessandra... Journal: European journal of cancer Issue: Volume 138(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Computed tomography densitometric study of anti-angiogenic effect of regorafenib in colorectal cancer liver metastasis. (13th February 2018) Authors: Reginelli, Alfonso; Clemente, Alfredo; Cardone, Claudia; Urraro, Fabrizio; Izzo, Andrea; Martinelli, Erika; Troiani, Teresa; Ciardiello, Fortunato; Brunese, Luca; Cappabianca, Salvatore Journal: Future oncology Issue: Volume 14:Number 28(2018) Page Start: 2905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer. Issue 4 (16th August 2019) Authors: Cardone, Claudia; Martinelli, Erika; Troiani, Teresa; Sforza, Vincenzo; Avallone, Antonio; Nappi, Anna; Montesarchio, Vincenzo; Andreozzi, Francesca; Biglietto, Maria; Calabrese, Filomena; Bordonaro, Roberto; Cordio, Stefano; Bregni, Giacomo; Febbraro, Antonio; Garcia-Carbonero, Rocio; Feliu, Jai... Journal: ESMO open Issue: Volume 4:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy. (June 2019) Authors: Ciardiello, Davide; Vitiello, Pietro Paolo; Cardone, Claudia; Martini, Giulia; Troiani, Teresa; Martinelli, Erika; Ciardiello, Fortunato Journal: Cancer treatment reviews Issue: Volume 76(2019) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer. Issue 9 (31st July 2019) Authors: Elez, Elena; Chianese, Chiara; Sanz‐García, Enrique; Martinelli, Erica; Noguerido, Alba; Mancuso, Francesco Mattia; Caratù, Ginevra; Matito, Judit; Grasselli, Julieta; Cardone, Claudia; Esposito Abate, Riziero; Martini, Giulia; Santos, Cristina; Macarulla, Teresa; Argilés, Guillem; Capdevila, Jau... Journal: Molecular oncology Issue: Volume 13:Issue 9(2019) Page Start: 1827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Resistance to anti-epidermal growth factor receptor in metastatic colorectal cancer: What does still need to be addressed?. (June 2020) Authors: Martini, Giulia; Ciardiello, Davide; Vitiello, Pietro Paolo; Napolitano, Stefania; Cardone, Claudia; Cuomo, Antonio; Troiani, Teresa; Ciardiello, Fortunato; Martinelli, Erika Journal: Cancer treatment reviews Issue: Volume 86(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗